Breaking News
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
December 8, 2018 - Study looks at ways technology can support nutritional needs of Parkinson’s patients
December 8, 2018 - Infant milk allergy is being overdiagnosed say experts
December 8, 2018 - Graphene may one day be used to test for ALS
December 8, 2018 - Houston Methodist launches real-time website to track flu cases
December 8, 2018 - RedHill Announces Positive Top-Line Results from Confirmatory Phase 3 Study with Talicia for H. pylori Infection
December 8, 2018 - A way to measure obesity and health beyond BMI
December 8, 2018 - New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies
December 8, 2018 - Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance
December 8, 2018 - Study quantifies links between alcohol, drug use and violent deaths
December 8, 2018 - Mothers’ stress levels at conception linked to child’s response to life challenges at age 11
December 8, 2018 - MIT researchers develop antimicrobial peptides from South American wasp’s venom
December 8, 2018 - Obesity prevention among low-income, diverse preschool-aged children and parents
December 8, 2018 - Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases
December 8, 2018 - CZI announces funding for open-source software efforts to improve image analysis in biomedicine
Innovative inhalation system to treat premature babies with lung diseases

Innovative inhalation system to treat premature babies with lung diseases

image_pdfDownload PDFimage_print

Premature babies who are born before their lungs have finished maturing often suffer from a lack of surfactant – a substance necessary for lung development. They are also particularly susceptible to illnesses of the respiratory organ, which have to be treated by means of inhalation. However, the inhalation systems available are not geared to the needs of preterm infants and newborns. Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM are working with partners to develop a system that would allow drugs to be administered as aerosols in an efficient and breath-triggered manner. This would shorten therapy duration, thereby easing the strain on little bodies.

Worldwide, around 15 million babies are born prematurely every year – and the trend is growing. Industrialized countries are no exception to this development. According to World Health Organization (WHO) figures, the rate in Germany is 9.2 per 100 newborns. One of the most common complications in premature babies is bronchopulmonary dysplasia, a chronic lung disease caused by the artificial ventilation that the infants often need. Also, because the preterm infants’ immune systems are not fully developed, they have an increased risk of infection. Lung infections are best treated with inhaled drugs. However, there are no inhalation systems that are specially adapted to the needs of premature babies and other newborns, as developing the corresponding technologies is very complicated due to the specific breathing characteristics of the tiny patients. Preterm infants typically have a high respiratory rate of 40 to over 60 breaths per minute and short inhalation periods of 0.25 to 0.4 seconds. On top of this, neonatal lungs have only a small tidal volume, posing extra difficulties for inhalation treatment. For this reason, scientists at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM in Hannover are working together with partners from industry and research to develop a new inhalation system allowing premature babies to receive an efficient inhalation therapy that is gentle on their lungs.

“Administering drugs to premature babies by means of inhalation is difficult. The current method of continuously delivering aerosols – that is, drugs in the form of particles – into the airflow is inefficient. For one thing, a large portion of the expensive drug gets lost on account of the inhalation/exhalation ratio and thus provides no medical benefit. Moreover, the aerosol is immediately diluted by the airflow traveling through the respirator,” says Dr. Gerhard Pohlmann, head of the Fraunhofer ITEM Division of Translational Biomedical Engineering. The project partners are developing a new breath-triggered method whereby the aerosol is administered directly to the nose only when the premature baby inhales. “For the first time, this opens the door to the highly efficient administration of drugs to preterm infants. This means that the amount of active ingredients can be reduced and therapy durations can be shortened. In addition, precise time control with very short inhalation boli permits the focused treatment of specific lung regions,” says Pohlmann. A similar system would also be fundamentally suitable for adult patients who require daily inhalation therapy. Shortening the administration time can substantially improve their quality of life.

Sensor film for monitoring the respiration of premature babies

The innovative inhalation system combines two technologies: A nasal prong with a miniature aerosol valve that is directly applied to the nose of the preterm infant. With a response time of just a few milliseconds, the aerosol valve allows the active ingredient to be released in a rapid, targeted manner. Opening of the valve is controlled by a sensor film. Laid on the abdominal wall of the premature baby, this flexible matrix uses sensors to detect the movement of the upper abdomen, thereby measuring the exact moment the baby breathes in. For the precise release of the aerosol, the measurement signal controls the micro valve via an intelligent algorithm. “The timing of the inhalation must be caught with an accuracy of about 20 milliseconds. Placing normal sensors in the exhalation region of a respirator does not permit this level of precision,” explains the researcher. The breath-triggered inhalation systems currently available are either reliant on measuring the breath signal in the breathing hose or else coupled to the ventilation system via an electrical connection. “Our ventilator-independent respiration recording system removes the need to interfere with an already approved device and thus reduces approval obstacles.”

Both the sensor film with ultra-thin ICs and the breath-triggered technology are being developed by a consortium in the FLEXMAX project (see box). The German Federal Ministry of Education and Research (BMBF) is funding the project, which addresses key aspects of the New Electronic Systems for Intelligent Medical Engineering (Smart Health) tender.

In tests with adults and in trials using devices that simulate the breathing of premature babies, there was an increase in efficiency of 60 percent compared to conventional inhalation technology. To be able to test the sensor film at an early stage in realistic conditions, the project partners are also developing an artificial abdominal wall that moves like that of a premature baby.

The complete inhalation system is currently available as a demonstrator, and it will take about three to five years before it is production-ready, says Pohlmann.

Breath-triggered administration of dry-powder drugs

The team of experts at Fraunhofer ITEM are also carrying out research into application systems for the administration of dry-powder formulas by means of inhalation, which could be used, for example, to treat premature babies with infant respiratory distress syndrome. This syndrome arises when the not fully developed lung either does not produce enough surfactant or does not produce any at all. Without surfactant, which reduces surface tension in the pulmonary alveoli, the lung is unable to expand. The baby suffers from oxygen deprivation and breathing distress and needs artificial respiration. Usually, surfactant obtained from animal lungs is flushed into the lung in the form of a suspension. The problem is that this so-called instillation is traumatic and the surfactant administered in a suspension does not spread as evenly through the lungs as aerosols do. In contrast, if the surfactant is administered as a moistened dry aerosol to be inhaled, it is distributed more homogeneously and works more effectively.

Source:

https://www.fraunhofer.de/en/press/research-news/2018/december/gentle-treatment-for-premature-babies-with-lung-diseases.html

Tagged with:

About author

Related Articles